ArticleDiabetes, obesity & metabolism2026

Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes.

Weronika Stupalkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.